Journey Medical CorporationDERMNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank55
3Y CAGR-40.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-40.6%/yr
vs -23.0%/yr prior
Acceleration
-17.6pp
Decelerating
Percentile
P55
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 10.36% |
| 2024 | -8.44% |
| 2023 | -26.16% |
| 2022 | 49.29% |
| 2021 | 0.00% |
| 2020 | -100.00% |
| 2019 | -88.92% |
| 2018 | 140.02% |
| 2017 | 139.33% |
| 2016 | 69.53% |